U.S. Court of Appeals for the Federal Circuit
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
This writing
- Type
- Opinion
- Filed
- April 1, 2024
- Case
- Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Case: 22-1258 Document: 70 Page: 1 Filed: 04/01/2024 United States Court of Appeals for the Federal Circuit ______________________ JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV, Plaintiffs-Appellees v. TEVA PHARMACEUTICALS USA, INC., MYLAN LABORATORIES LTD., Defendants-Appellants ______________________ 2022-1258, 2022-1307…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.